Across
- 5. Brand behind the first OTC eczema lotion with microbiome-friendly certification
- 6. Type of debridement found to be faster than autolytic in severe wounds
- 7. Subcutaneous form of this drug showed improved plaque psoriasis outcomes vs oral
- 9. Company behind precision laser innovation validated in a JAAD study
- 13. Emerging delivery system targeting sebaceous glands in nodular acne
- 14. Abbreviation for organization that awarded seal of acceptance to Codex labs lotion
- 15. Alphyn’s investigational hydrogel currently in phase 2b trial for atopic dermatitis
Down
- 1. Vasoconstrictor cream shown to reduce erythema in rosacea
- 2. Hormonal life stage associated with under-addressed acne in women
- 3. Investigational drug showing efficacy in moderate to severe psoriasis
- 4. Type of psoriasis with notable disease burden in recent Korean epidemiologic study
- 8. JAK inhibitor evaluated for its potential to treat Netherton Syndrome
- 10. AI model outperforming others in keloid vs malignancy classification without dermoscopy
- 11. Organization renewing WHO partnership to combat corticosteroid misuse globally
- 12. Surname of researcher behind a new scale for measuring facial redness